Immuneering Corp
IMRX
$3.79-1.94%
Delayed · as of Oct 13, 2026, 10:30 AM ET
Mkt cap
$124.15M
EV/Sales
N/A
P/E ratio
N/A
FY2023 Revenue
N/A
EPS (H1 2026)
$-0.48
Gross Margin (FY2023)
N/A
Profit Margin (FY2023)
N/A
Beta
0.00
Div yield
N/A
Sector
Healthcare
Immuneering Corp (IMRX) is a biotechnology company listed on US.
Latest reported IMRX revenue for 2023-12-31 was $0. Net income was -$53.5M. Revenue was down 100.0% from 2022-12-31 to 2023-12-31. IMRX currently screens at market cap $124.2M.
Use this IMRX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full IMRX income, balance, and cash tables.
Immuneering Corp (IMRX) is a biotechnology company in the Healthcare sector.
Latest cached Immuneering Corp (IMRX) net income for Dec 31, 2023 was -$53.5M. Statements: https://lician.com/financials/imrx
Immuneering Corp (IMRX) market capitalization is $124.2M on the latest cached snapshot.
Immuneering Corp (IMRX) cached previous close $3.86; day range $3.79 – $3.86; volume 47,832. Session quote: https://lician.com/quote/imrx
Immuneering Corp (IMRX) latest cached earnings event is "IMRX earnings" on Aug 12, 2026. Earnings calendar: https://lician.com/earnings
The latest cached IMRX filing is 8-K · Aug 5, 2026. Filings: https://lician.com/sec/imrx